The Department of Health and Social Care and UK Health Security Agency are addressing regulatory failures in the private COVID-19 testing market for international travel, which expanded from 11 to 400+ firms between December 2020 and September 2021 but lacks consumer protections. The market has suffered from unclear pricing, misleading advertisements, and delayed results, with UKAS providing accreditation through a three-stage process. Government intervention is needed to establish functional market regulation and consumer safeguards as testing requirements persist internationally.
In response to: Private coronavirus (COVID-19) testing validation
In response to: Private coronavirus (COVID-19) testing validation
This consulation is seeking to collect views on proposals for private COVID-19 testing validation. We are particularly interested in hearing from businesses involved in the manufacturer, distribution and retail of COVID-19 tests and expert academic views.
This is a public consultation on proposals to introduce mandatory laboratory validation for COVID-19 test products before entry to the UK market, under the Medicines and Medical Devices Act 2021.
This is a public consultation on proposals to introduce mandatory laboratory validation for COVID-19 test products before entry to the UK market, under the Medicines and Medical Devices Act 2021.
In response to: Validation of COVID-19 tests: laboratory validation
This consulation is seeking to collect views on proposals for private COVID-19 testing validation. We are particularly interested in hearing from businesses involved in the manufacturer, distribution and retail of COVID-19 tests and expert academic views.
This consulation is seeking to collect views on proposals for private COVID-19 testing validation. We are particularly interested in hearing from businesses involved in the manufacturer, distribution and retail of COVID-19 tests and expert academic views.